1282614-60-1

Basic information

• Product Name: 3-[(4-{5-[butyl(2-fluorobenzoyl)amino]-1,3,4-thiadiazol-2-yl}benzoyl)amino]-2-hydroxypropanoic acid
• Synonyms: 3-[(4-{5-[butyl(2-fluorobenzoyl)amino]-1,3,4-thiadiazol-2-yl}benzoyl)amino]-2-hydroxypropanoic acid
• CAS NO: 1282614-60-1
• Molecular Weight: 486.524
• Mol File: 1282614-60-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-[(4-{5-[butyl(2-fluorobenzoyl)amino]-1,3,4-thiadiazol-2-yl}benzoyl)amino]-2-hydroxypropanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(4-{5-[butyl(2-fluorobenzoyl)amino]-1,3,4-thiadiazol-2-yl}benzoyl)amino]-2-hydroxypropanoic acid(1282614-60-1)
• EPA Substance Registry System: 3-[(4-{5-[butyl(2-fluorobenzoyl)amino]-1,3,4-thiadiazol-2-yl}benzoyl)amino]-2-hydroxypropanoic acid(1282614-60-1)

Safety Data

• Hazardous Substances Data: 1282614-60-1(Hazardous Substances Data)

Upstream product

• 1220709-01-2 methyl 4-(5-(N-butyl-2-fluorobenzamido)-1,3,4-thiadiazol-2-yl)benzoate 
• 1220708-68-8 4-(5-(butylamino)-1,3,4-thiadiazol-2-yl)benzoic acid methyl ester 
• 6610-31-7 4-butyl-3-thiosemicarbazide 
• 592-82-5 butyl isothiocyanate 
• 632-12-2 (RS)-isoserine 
• 1220709-02-3 4-(5-(N-butyl-2-fluorobenzamido)-1,3,4-thiadiazol-2-yl)benzoic acid 

Relevant articles and documents

New thiadiazole derivatives

The present invention relates to thiadiazole derivatives of formula (I), to processes for their preparation and to pharmaceutical compositions containing them. These compounds are potent agonists of S1P1 receptors and thus, they are useful in the treatment, prevention or suppression of diseases and disorders known to be susceptible to improvement by sphingosine-1-phosphate receptors agonists (S1P1), such as autoimmune diseases, chronic immune and inflammatory diseases, transplant rejection, malignant neoplastic diseases, angiogenic-related disorders, pain, neurological diseases, viral and infectious diseases.